J K Rockstroh
Long-term quantitative hepatitis B surface antigen (HBsAg) trajectories in persons with and without HBsAg loss on tenofovir-containing antiretroviral therapy.
Begré L, Boyd A, Salazar-Vizcaya L, Suter-Riniker F, Béguelin C, Rockstroh J, Günthard H, Calmy A, Cavassini M, Stoeckle M, Schmid P, Bernasconi E, Levrero M, Zoulim F, Wandeler G, Rauch A, Swiss HIV Cohort Study (SHCS). Long-term quantitative hepatitis B surface antigen (HBsAg) trajectories in persons with and without HBsAg loss on tenofovir-containing antiretroviral therapy. HIV Med 2023; 25:291-298.
Oct 10, 2023Long-term quantitative hepatitis B surface antigen (HBsAg) trajectories in persons with and without HBsAg loss on tenofovir-containing antiretroviral therapy.
Oct 10, 2023HIV Med 2023; 25:291-298
Begré Lorin, Boyd Anders, Salazar-Vizcaya Luisa, Suter-Riniker Franziska, Béguelin Charles, Rockstroh J K, Günthard Huldyrich F, Calmy Alexandra, Cavassini Matthias, Stoeckle Marcel, Schmid Patrick, Bernasconi Enos, Levrero Massimo, Zoulim Fabien, Wandeler Gilles, Rauch Andri, Swiss HIV Cohort Study (SHCS)
[Immunoglobulin therapy for systemic lupus erythematosus]
Utku N, von Kempis J, Rockstroh J, Sauerbruch T. [Immunoglobulin therapy for systemic lupus erythematosus]. Immunität und Infektion 1993; 21 Suppl 1:26-7.
Apr 1, 1993[Immunoglobulin therapy for systemic lupus erythematosus]
Apr 1, 1993Immunität und Infektion 1993; 21 Suppl 1:26-7
Utku N, von Kempis Johannes, Rockstroh J K, Sauerbruch T